Xcout Intel
Immy Inc.
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Subscribe to see Immy Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immy Inc. at a glance
Immy Inc. is a medical diagnostics company headquartered in United States. It has raised at least $4.2M across the 9 funding rounds on record. Its most recent funding round raised $536,167 in November 2020. Xcout tracks 7 named people at Immy Inc., including Sean Bauman (CEO).
Immy Inc. leadership
- Sean BaumanCEO
- Tim HeefnerPresident
- Joy PelfreyCOO
- Tom ChillerChief Medical Officer (CMO) and VP of Strategic Innovation
- JT HarrisonSenior Vice President of Business & Product Development
- Kevin KurimskyVice President of Global Sales & Marketing
1 more named person on record for Immy Inc., with roles, board committees and tenure — see the full roster →
Immy Inc. funding rounds
At least $4.2M raised across the 9 rounds on record. The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $536,167 | — | |
| SEC Form D filing | $380,526 | — | |
| SEC Form D filing | $50,000 | — | |
| SEC Form D filing | $100,000 | — | |
| SEC Form D filing | $146,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Immy Inc. competitors
A few of Immy Inc.'s closest competitors — see the full list of competitors and alternatives →
Hycor Biomedical LLC provides IgE allergy testing lab solutions and diagnostic products, including the Noveos system, reagents, and microparticle testing technology. The company serves healthcare professionals and laboratories by offering precision allergy diagnostics, workflow guidance, and technical support to enable efficient patient management.
EUROIMMUN is a global manufacturer of test systems and automation solutions for medical laboratory diagnostics, specializing in autoimmune, infectious, and neurological diseases.
Sansure Biotech Inc., founded in Changsha, China, in 2008, is dedicated to the global development and commercialization of advanced diagnostic and research products. The company offers a diverse range of solutions, including upstream nucleic acid extraction kits, real-time PCR systems for both clinical and investigative purposes, and fluorescence detection platforms. Their extensive product portfolio encompasses diagnostic assays for critical conditions like the novel coronavirus, viral hepatitis, and AIDS. Furthermore, they provide blood screening and general extraction kits, tests for cancer-related biomarkers, and solutions for respiratory, sexually transmitted, digestive tract, prenatal, postnatal, and genetic diseases. Sansure Biotech also supplies essential laboratory instrumentation and various consumables, primarily serving hospitals and scientific laboratories worldwide.
HUMAN Diagnostics Worldwide is a German manufacturer and supplier of in vitro diagnostic equipment, reagents, and laboratory solutions for clinical diagnostics.
Biocare Medical develops and supplies advanced staining instruments, primary antibodies, and detection reagents for immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The company serves clinical laboratories, research facilities, and pathologists by providing integrated automated staining platforms and testing solutions.
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Get Immy Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Immy Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 9 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access